NEWSWIRETODAY Press Release& Newswire Distribution | HOME
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: The Scott Partnership
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

GSK Head of Patient Recruitment Joins Exco InTouch - Exco InTouch announces the new appointment of Director of Patient Recruitment, Judith Teall
GSK Head of Patient Recruitment Joins Exco InTouch


NewswireToday - /newswire/ - Sawbridgeworth, Hertfordshire, United Kingdom, 2010/09/02 - Exco InTouch announces the new appointment of Director of Patient Recruitment, Judith Teall.

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Exco InTouch, the leading provider of mobile patient communication solutions for the pharmaceutical and healthcare sectors, announces the new appointment of Director of Patient Recruitment, Judith Teall. The newly created position will drive Exco InTouch to build on its “patient centric” approach to managing clinical trials by identifying barriers to recruitment and retention, enhancing the crucial relationship between patient, trial processes and the sponsor company. Based at Exco InTouch’s European headquarters in Hertfordshire, UK, Teall’s role will see her lead and direct patient engagement solutions, lending her first-rate experience to further develop Exco’s recruitment, retention and compliance suite of services for the company’s biopharmaceutical sponsors and Contract Research Organization (CRO) clients.

Validating Exco InTouch’s growing stature in the eClinical arena, Teall joins the team with a distinguished patient recruitment background from Glaxo SmithKline, where she headed up patient recruitment across Europe, Asia Pacific, Africa and the Middle East. With over 20 years’ experience in the pharmaceutical clinical research area, Teall originally graduated from the Sheffield School of Nursing and spent her early career as a RGN nurse. Teall has an extensive understanding and insight into the healthcare arena through a variety of roles, firmly establishing herself as recruitment expert in the clinical research industry. Her work in guiding recruitment excellence, including developing enrolment strategies and delivering global monitoring training methods strengthens Exco’s global focus on patient recruitment and retention.

“Exco InTouch has been built on a very strong base of experienced personnel coupled with the innovative use of technology and service excellence, and is already well placed in the patient recruitment, retention and compliance arena. This was a key driver in my decision to join the company,” says Teall. “Exco’s industry expertise and commitment to a patient centric approach to developing all its services, made it an ideal match for my expertise in patient recruitment. I am looking forward to further enhancing the standards of global patient recruitment through effective enrolment and engagement strategies.”

Tim Davis, CEO, Exco InTouch, comments: “We believe in putting the patient experience at the heart of everything we do at Exco. Welcoming someone of Judith’s capabilities to our team further enhances our ability to develop these recruitment and engagement strategies and we see Judith as a vital addition to our efforts on this front. With her extensive experience in the industry, we believe Judith will be a key member of the team. Exco has grown significantly by innovative but pragmatic service development especially in the patient recruitment process and with this new appointment we plan to maximise the opportunity for recruitment, communication and engagement with all patient populations.”

Exco InTouch is the leading provider of regulatory compliant mobile technologies for recruitment, retention, compliance, engagement and data capture to the pharmaceutical and healthcare industries.

For further information on the Exco InTouch range of solutions, please call +44 1279 408 210 or +1 949 725 2946

About Exco InTouch
Exco InTouch ( is the leading provider of interactive patient communication solutions using internet and cell phone technology. Using a combination of software and services, Exco InTouch offers BioPharma sponsors, CROs and patient recruitment agencies the opportunity to improve patient recruitment, retention and compliance using timely notifications, alerts and two-way messages.

Additionally, Exco collects electronic patient reported outcomes (ePRO) and diary data using standard cell phone technology which is both cost effective for sponsors and extremely easy and convenient for trial subjects. These solutions are currently being used by hundreds of thousands of patients in over 70 countries, delivered in the local language and are fully compliant with HIPAA regulations, FDA CFR 21 Part 11 and all electronic communication privacy directives.

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Written by / Agency / Source: The Scott Partnership


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick NewswireToday Visibility Checker


Distribution / Indexing: [+]

# # #

  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!

GSK Head of Patient Recruitment Joins Exco InTouch

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
Publisher Contact: 
+44(0)14 7753 9539 exco[.]
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any The Scott Partnership securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Articles From The Scott Partnership / Company Profile

Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Celltrion Pharm Selects TrackWise QMS for Scalability and Data Integrity
Ipsen Adds Another Program into its Pre-clinical R&D Oncology Pipeline through An Exclusive Worldwide Collaboration with Accent Therapeutics
Evaxion Biotech Lauded by Frost & Sullivan for Helping Develop Highly Targeted Therapies with its AI Immunology Platforms
Kyowa Hakko Acclaimed by Frost & Sullivan for its Non-GMO, Allergen-free, Immune Support Paraprobiotic Ingredient, IMMUSE™
DSM to Acquire First Choice Ingredients to Accelerate Growth in Food and Beverage
STEMCELL Technologies Launches Human Pluripotent Stem Cell Characterization and Banking Services in Partnership with WiCell
Biocon Selects TrackWise to Enable Enterprise Quality Management Across Global Biopharmaceutical Operations
STEMCELL Technologies and Hubrecht Organoid Technology to Partner on Non-Oncology Organoid Drug Screening Services
Ipsen and Exicure Enter into Exclusive Collaboration Targeting Rare Neurodegenerative Disorders
Ipsen Strengthens its Pre-clinical Oncology Pipeline with An Exclusive Worldwide-collaboration with BAKX Therapeutics, Inc. for BKX-001
Pharma and Biotech to Highly Invest in RNA Therapeutics to Expedite Research & Development across the Globe Finds Frost & Sullivan
Parexel Commended by Frost & Sullivan for Developing a Flexible and Agile Delivery Model to Improve Clinical Trial Outcome
Ipsen and IRLAB Enter Exclusive Worldwide Licensing Agreement Aimed to Improve the Lives of People Living with Parkinson’s Disease
Exelixis and Ipsen Announce Cabozantinib in Combination with An Immune Checkpoint Inhibitor Significantly Improved Progression
Ipsen Opts-in to Join Exelixis with Ongoing Development of Cabometyx® for People Living with A Form of Thyroid Cancer

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business




  ©2021 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (